<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="females, with males 65% more likely to die from the" exact="infection" post="than females. Data from the World Health Organization (WHO)"/>
 <result pre="with emerging observations, indicating a large, sex-dependent gap in disease" exact="infection" post="and outcomes for SARS-CoV-2 disease (COVID-19) as for previous"/>
 <result pre="estrogen receptor antagonists caused increased mortality in females after SARS-CoV" exact="infection" post="[7]. This observation also strongly agrees with the fact"/>
 <result pre="interaction is a key determinant for the success of viral" exact="infection" post="and receptivity [35]. Recently, the S-protein/ACE2 interface has been"/>
 <result pre="the multistep pathogenesis and the age/sex-gaps of such a complex" exact="infection" post="and progression, considering also that ACE2 (locus Xp22.2) and"/>
 <result pre="binding of the spike protein to the host cell, inhibiting" exact="infection" post="rate and mortality, are a valuable rationale to start"/>
 <result pre="rate and mortality, are a valuable rationale to start heparin" exact="treatment" post="in selected COVID-19 patients [59,60,61,62]. This approach might have"/>
 <result pre="and glomerulosclerosis [64,65]. These alterations are reversed or ameliorated by" exact="treatment" post="with ACE-inhibitors or Ang-receptors blocker (ARBs) [37,63,66,67], whether or"/>
 <result pre="(rhACE2) [68,69,70]. Intuitively, this strategy could also be a possible" exact="treatment" post="for COVID-19 patients with a double effect: excessive soluble"/>
 <result pre="during ACE2 receptor suppression, as in the presence of SARS-CoV-2" exact="infection" post="[35,37]. Interestingly, a quantitative variation in ACE1 levels has"/>
 <result pre="(rs495828, gene promoter, and rs8176746, exon 7) influence ACE inhibitors" exact="treatment" post="response [90,91,92], and might contribute in reducing SARS-CoVsâ€™ transmission,"/>
 <result pre="COVID-19 patients, those taking RAS-inhibitors may take advantage of the" exact="treatment" post="considered an adjuvant drug for RAS rebalancing [40,75]. Finally,"/>
 <result pre="domain could affect ACE2-SARS-CoV-2 interaction [105,108], as demonstrated by chloroquine" exact="treatment" post="of SARS-CoV patients, in which chloroquine inhibited virus infection"/>
 <result pre="chloroquine treatment of SARS-CoV patients, in which chloroquine inhibited virus" exact="infection" post="by interfering with the terminal glycosylation of ACE2 receptor"/>
 <result pre="to show a greater humoral and cell-mediated immune response to" exact="infection" post="[117,118,119]. Consequently, females clear infections more quickly and more"/>
 <result pre="shows an apparent negative correlation between ACE2 quantitative expression and" exact="infection" post="susceptibility and severity at population level [131]. Nevertheless, the"/>
 <result pre="disease [141]. The role of the cytokine storm in SARS-CoV-2" exact="infection" post="is attracting great attention as a crucial phase to"/>
 <result pre="account for the low risk and better prognosis of SARS-CoV-2" exact="infection" post="in females, though a multidisciplinary approach for such complex"/>
 <result pre="quality has been suggested to lead to an increased COVID-19" exact="infection" post="rate probability due to a direct effect of air"/>
 <result pre="equipment are key issues [176] to avoid front-line healthcare worker" exact="infection" post="risk and increased psychological burden, particularly for medical doctors"/>
 <result pre="Finally, considering individual genetic susceptibility or environmental influences on virus" exact="infection" post="and/or SARS progression, a wide and heterogeneous geographical distribution"/>
 <result pre="cases/4,452,638 habitants; male/female ratio 48.6/51.4). It accounts for an overall" exact="infection" post="rate of about 0.59%, characterized by 3,366 deaths (14.2%"/>
 <result pre="confirmed cases/346,975 habitants; male/female ratio 48.1/51.9) accounting for an overall" exact="infection" post="rate of about 0.27%, compared with the town of"/>
 <result pre="confirmed cases/286,781 habitants; male/female ratio 48.9/51.1) accounting for an overall" exact="infection" post="ratio of about 1.5% (Ferrara vs. Piacenza; p&amp;lt; 0.00001;"/>
 <result pre="is very close to the most critical hot-spot of the" exact="infection" post="in Italy [region Lombardia (0.83%); Lodi (1.43%), Codogno area"/>
 <result pre="interactions, has a great role in determining immunity, survival, and" exact="treatment" post="responses in different populations. 6. Conclusions The COVID-19 pandemic"/>
 <result pre="Different sex and age groups have strongly different susceptibilities to" exact="infection" post="and mortality, considering male-sex, old age, and comorbidities as"/>
 <result pre="explain some controversial data. Considering individual genetic susceptibility to virus" exact="infection" post="and progression, heterogeneous geographical distributions are now emerging not"/>
 <result pre="human emergenceNat. Med.2015211508151310.1038/nm.398526552008 4.AlagailiA.N.BrieseT.MishraN.KapoorV.SameroffS.C.BurbeloP.D.de WitE.MunsterV.J.HensleyL.E.ZalmoutI.S.et al.Middle East respiratory syndrome coronavirus" exact="infection" post="in dromedary camels in Saudi ArabiamBio20145e00884-1410.1128/mBio.00884-1424570370 5.DrostenC.GuntherS.PreiserW.van der WerfS.BrodtH.R.BeckerS.RabenauH.PanningM.KolesnikovaL.FouchierR.A.et"/>
 <result pre="Coll. Cardiol.202010.1016/j.jacc.2020.04.031 21.ThachilJ.The versatile heparin in COVID-19J. Thromb. Haemost.202010.1111/jth.1482132239799 22.TangN.BaiH.ChenX.GongJ.LiD.SunZ.Anticoagulant" exact="treatment" post="is associated with decreased mortality in severe coronavirus disease"/>
 <result pre="with receptorScience20053091864186810.1126/science.111648016166518 109.VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.SeidahN.G.NicholS.T.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol. J.200526910.1186/1743-422X-2-6916115318 110.ZamboniP.GemmatiD.Clinical implications of gene polymorphisms in"/>
 <result pre="infected with 2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 142.XuX.HanM.LiT.SunW.WangD.FuB.ZhouY.ZhengX.YangY.LiX.et al.Effective" exact="treatment" post="of severe COVID-19 patients with tocilizumabProc. Natl. Acad. Sci."/>
 <result pre="175.DaughtonC.The international imperative to rapidly and inexpensively monitor community-wide Covid-19" exact="infection" post="status and trendsSci. Total Environ.202072613814910.1016/j.scitotenv.2020.13814932315842 176.YangY.WangH.ChenK.ZhouJ.DengS.WangY.Shelter hospital mode: How"/>
 <result pre="Total Environ.202072613814910.1016/j.scitotenv.2020.13814932315842 176.YangY.WangH.ChenK.ZhouJ.DengS.WangY.Shelter hospital mode: How to prevent novel coronavirus" exact="infection" post="2019 (COVID-19) hospital-acquired infection?Infect. Control Hosp. Epidemiol.202010.1017/ice.2020.9732223769 177.LaiJ.MaS.WangY.CaiZ.HuJ.WeiN.WuJ.DuH.ChenT.LiR.et al.Factors"/>
 <result pre="(left) characterized by a balanced ACE1/ACE2 pathway, and during SARS-CoV-2" exact="infection" post="condition (right) in which SARS-CoV-2 mediated suppression of ACE2"/>
 <result pre="rs4340, rs13447447) in combination with ACE2 downregulation due to SARS-CoV-2" exact="infection" post="and/or in the presence of the ACE2 8790 G-allele"/>
 <result pre="rs4340, rs13447447) in combination with ACE2 downregulation due to SARS-CoV-2" exact="infection" post="counteracted by the ACE2 8790 A-allele (i.e., rs2285666), resulting"/>
</results>
